2022 Career Support Funds Granted
In 2022, we delivered almost $9.8 million across 19 fellowship grants, supporting both emerging and established cancer researchers.
Career Development Fellowships are for mid-career researchers who demonstrate the potential to undertake research that will have major significance to cancer outcomes.
View the Career Development Fellows >
Early Career Fellowships are aimed at encouraging researchers to build on their research capability and become leaders of their own research team.
View the Early Careers Fellows >
2022 Career Development Fellowships
Dr Frances Byrne is one of seven researchers in NSW we supported in 2022 with a Career Development Fellowship.
Dr Byrne, from the University of NSW, is leading a fellowship to investigate new treatments for liver cancer – the second fastest growing cancer type in Australia, and the fastest growing cause of cancer deaths.
View the other esteemed recipients of the 2022 Career Development Fellowships below.
| Administering Institution | Grantee | Grant Title | Funding (excl. GST) | |
|---|---|---|---|---|
|
Macquarie University |
Associate Professor Reema Harrison | Co-designing quality end of life care for culturally and linguistically diverse people with cancer |
$598,796 |
|
|
University of New South Wales |
Dr Frances Byrne |
Investigating the potential of a new mitochondrial uncoupler for the treatment of liver cancer |
$150,000 |
|
|
University of New South Wales |
Dr Antoine de Weck |
Identifying novel drug targets for paediatric oncology |
$570,660 |
|
|
University of New South Wales |
Dr Ben Smith |
Improving consistency and equity of care for fear of cancer recurrence through an evidence-based, culturally sensitive and implementation-ready clinical pathway |
$592,165 |
|
|
University of Sydney |
Dr Jessamy Tiffen |
Why are men more likely to die from cancer compared to women? A study of X-linked epigenetic regulators in melanoma |
$596,829 |
|
|
University of Technology Sydney |
Associate Professor Majid Ebrahimi Warkiani |
A vascularised lung-on-a-chip model for nanotoxicity testing |
$592,300 |
|
|
University of Wollongong |
Dr Thuy Tran |
Enabling next generation radiotherapy for cancer: Development of novel Quality Assurance instrumentation for Proton Therapy |
$600,000 |
|
|
$3,700,749.72 |
||||
2022 Early Career Fellowships
Dr Brooke Pereira is one of 12 researchers in NSW we supported in 2022 with an Early Career Fellowship.
Dr Pereira's fellowship will support her work in personalised medicine approaches for treating pancreatic cancer.
View the other esteemed recipients of the 2022 Early Career Fellowships below.
| Administering Institution | Grantee | Grant Title | Funding (excl. GST) | |
|---|---|---|---|---|
|
University of Newcastle |
Dr Rebecca Wyse | The effectiveness, cost-effectiveness and acceptability of a digital health intervention to support breast cancer patients prepare for and recover from surgery: A randomised controlled trial |
$599,600 |
|
|
University of Newcastle |
Dr Yuchen Feng | Exploring long noncoding RNA vulnerabilities of metabolism for cancer treatment |
$597,930 |
|
|
University of Newcastle |
Dr Heather Murray | Targeting the spliceosome as a novel approach for acute myeloid leukaemia (AML) therapy |
$600,000 |
|
|
University of New South Wales |
Dr Brooke Pereira | Personalised medicine approaches for anti-fibrotic targeting and Gemcitabine/Abraxane treatment in pancreatic cancer guided by intravital (in vivo) imaging |
$456,151 |
|
|
University of New South Wales |
Dr Benjamin Daniels | Leveraging big data for real-world evidence generation: Impact of multi-medicine use on bowel cancer treatment and survivorship outcomes |
$345,000 |
|
|
University of New South Wales |
Dr Kendelle Murphy | A personalised approach to uncoupling the tumour-stroma feedback loop using the phase II ready FAK inhibitor, AMP945, in combination with standard-of-care chemotherapy in pancreatic cancer guided by Merlin status |
$444,500 |
|
|
University of New South Wales |
Dr Abbas Habibalahi |
A novel imaging technology for non-invasive diagnostics of ocular surface squamous neoplasia (OSSN) |
$310,433 |
|
|
University of Sydney |
Dr Tess Reynolds |
Improving quality of life for metastatic spine patients |
$415,000 |
|
|
University of Sydney |
Dr Ines Silva |
Matching optimal drug therapy to overcome organ-specific resistance to standard immunotherapy in melanoma |
$600,000 |
|
|
University of Sydney |
Dr Hui Emma Zhang |
Understanding a unique enzyme family and a new therapeutic approach for primary liver cancer |
$600,000 |
|
|
University of Wollongong |
Dr Saree Alnaghy |
Bringing Colour to Radiotherapy: Developing Next-generation X-ray Imaging to Guide Radiotherapy |
$599,840 |
|
|
Western Sydney University |
Dr Carolina Sandler |
Improving management of post-cancer fatigue by facilitating access to evidence-based care. |
$592,951 |
|
|
$6,161,405 |
||||